Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 6.01132 | 83 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.86895 | 81 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.90077 | 82 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.8421 | 80 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.74545 | 80 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 6.26085 | 86 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.99998 | 84 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.95895 | 82 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.75704 | 81 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.744 | 80 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.85485 | 82 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.78724 | 81 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.70228 | 80 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.85804 | 82 |